ACPE program for Acute Answers for a Chronic Care Problem: Identifying and Addressing the Long-Term Management of Gout

Program Description

Gout is a common and increasingly prevalent cause of acute and chronic arthritis and is the most common inflammatory arthritis in men. Nevertheless, gout has not been widely recognized and managed as a chronic disease. A general change in recognizing the long-term nature of gout is necessary to successfully manage patients with a chronic care approach.

Learning Objectives

Pharmacists

1. Recognize acute gout flares as warning signs of the underlying chronic disease
2. State the importance and misconceptions of serum urate levels in clinical practice for gout patients

Target Audience

This activity is designed for physicians, nurse practitioners, physician assistants, nurses, and pharmacists with a special interest in the diagnosis and management of gout and hyperuricemia.

Faculty/Disclosures

It is the policy of the University of Pennsylvania School of Medicine for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provides products or services that may be relevant to the content of this CME activity. For this purpose, we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous, and evidence-based presentations.

The staff in the Office of CME at the University of Pennsylvania School of Medicine, Purdue University School of Pharmacy and Pharmaceutical Sciences, and TCL Institute, LLC, and the peer reviewer, Zalman Agus, MD, have reported no relevant financial relationships with any commercial interests related to the content of this educational activity.

Dr. Lieberman reported that he is a consultant to URL Pharma, Inc. He also reported that he is a speaker for Takeda Pharmaceuticals North America, Inc.

Dr. Fromer has disclosed no relevant financial relationships with any commercial interests related to the content of this educational activity.

Relevant Financial Relationships
Financial relationships are those relationships in which the individual benefits by receiving salary, royalty, intellectual property rights, consulting fees, honoraria, ownership interest (eg, stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected.

Accreditation

Pharmacists:

Purdue University School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is an knowledge-based continuing education activity of Purdue University, an equal access/equal opportunity institution. Universal Activity Number (UAN): 0018-9999-10-011-H01-P, .25 contact hours (.025 CEU). Release Date: 3/15/2010; Expiration Date:3/15/2011

Provider

Commercial Support

The activity is supported by an educational grant from Takeda Pharmaceuticals North America, Inc.

Disclosure of Unlabeled Use

The University of Pennsylvania School of Medicine requires all faculty to disclose any planned discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.

The faculty for this activity have indicated that the presentation will not contain any mentions of investigational and/or off-label use of products.

Instruction for Participation

Release date: 03/15/2010
Expiration date: 03/15/2011
This activity was last reviewed on: 03/15/2010

This online activity should take approximately 0.25 hours to complete. The participant should:
1. Read the objectives and other CME/CPE/CE information.
2. Take the pretest
3. Complete the XM Radio activity.
4. Take the posttest and complete a short evaluation following the activity. The evaluation on www.reachmd.com provides you with the opportunity to comment on the extent to which the educational needs were met, the quality of the instructional process, the perception of enhanced professional effectiveness, the perception on commercial bias, and your view on future educational needs.
5. Participants who complete the posttest and evaluation will then be prompted to print their CME/CPE/CE certificate. No additional certificate will be mailed. Expiration date for credit is 03/15/2011.
6. For questions regarding CME for this activity, you may reach the Office of CME at the University of Pennsylvania School of Medicine at http://www.med.upenn.edu/cme/.
7. Please contact TCL Institute, LLC with any other questions via phone, (919) 467-0006 ext 233.